FR607M - - Google Patents

Info

Publication number
FR607M
FR607M FR837423A FR837423A FR607M FR 607 M FR607 M FR 607M FR 837423 A FR837423 A FR 837423A FR 837423 A FR837423 A FR 837423A FR 607 M FR607 M FR 607M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR837423A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR789324A external-priority patent/FR1268445A/fr
Application granted granted Critical
Publication of FR607M publication Critical patent/FR607M/fr
Application filed filed Critical
Priority to FR837423A priority Critical patent/FR607M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR837423A 1958-03-13 1961-08-31 Active FR607M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR837423A FR607M (fr) 1958-03-13 1961-08-31

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72110458A 1958-03-13 1958-03-13
FR789324A FR1268445A (fr) 1958-03-13 1958-03-13 Dérivés de la pyrrolo [2. 3-d] pyrimidine et leur préparation
FR837423A FR607M (fr) 1958-03-13 1961-08-31

Publications (1)

Publication Number Publication Date
FR607M true FR607M (fr) 1961-06-19

Family

ID=24896553

Family Applications (1)

Application Number Title Priority Date Filing Date
FR837423A Active FR607M (fr) 1958-03-13 1961-08-31

Country Status (3)

Country Link
ES (1) ES247857A1 (fr)
FR (1) FR607M (fr)
GB (2) GB915304A (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3311628A (en) * 1965-03-09 1967-03-28 Bristol Myers Co Derivatives of pyrrolo [2, 3-d] pyrimidine
CH592668A5 (fr) * 1973-10-02 1977-10-31 Delalande Sa
ES2109796T3 (es) * 1994-05-03 1998-01-16 Ciba Geigy Ag Derivados de pirrolopirimidilo con efecto antiproliferante.
YU76100A (sh) 1998-06-02 2003-12-31 Osi Pharmaceuticals Inc. Pirolo(2,3-d) pirimidin preparati i njihova primena
US6878716B1 (en) 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
US6686366B1 (en) 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
WO1999065908A1 (fr) 1998-06-19 1999-12-23 Pfizer Products Inc. COMPOSES DE PYRROLO[2,3d]PYRIMIDINE
PA8474101A1 (es) 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
US7160890B2 (en) 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6664252B2 (en) 1999-12-02 2003-12-16 Osi Pharmaceuticals, Inc. 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
US6680322B2 (en) 1999-12-02 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
GEP20053479B (en) 1999-12-10 2005-03-25 Pfizer Prod Inc Pyrrolo[2,3-d]Pyrimidine Compounds, Pharmaceutical Composition Containing the Same and Use
US6673802B2 (en) 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
DE10148883A1 (de) * 2001-10-04 2003-04-10 Merck Patent Gmbh Pyrimidinderivate
EP1450811B1 (fr) 2001-11-30 2009-10-21 OSI Pharmaceuticals, Inc. Composés specifiques aux recepteurs A1 et A3 de l'adenosine et leur utilisations
AU2002366811B2 (en) 2001-12-20 2009-01-15 Osi Pharmaceuticals, Inc. Pyrimidine A2B selective antagonist compounds, their synthesis and use
US20030229067A1 (en) 2001-12-20 2003-12-11 Arlindo Castelhano Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use
AU2003276591A1 (en) 2002-11-26 2004-06-18 Pfizer Products Inc. Method of treatment of transplant rejection
WO2007084667A2 (fr) * 2006-01-19 2007-07-26 Osi Pharmaceutical, Inc. Inhibiteurs de kinase heterobicycliques fusionnes
PT2384326E (pt) 2008-08-20 2014-06-09 Zoetis Llc Compostos de pirrolo[2,3-d]pirimidina
NL2022471B1 (en) 2019-01-29 2020-08-18 Vationpharma B V Solid state forms of oclacitinib

Also Published As

Publication number Publication date
GB915304A (en) 1963-01-09
GB915303A (en) 1963-01-09
ES247857A1 (es) 1959-08-16

Similar Documents

Publication Publication Date Title
FR607M (fr)
JPS523248B1 (fr)
DE1070266B (fr)
AT221043B (fr)
AT217439B (fr)
JPS386205B1 (fr)
FR447M (fr)
AT215751B (fr)
AT216227B (fr)
AT216612B (fr)
AT216831B (fr)
AT216803B (fr)
DE1059305C2 (fr)
AT216771B (fr)
AT217982B (fr)
AT219815B (fr)
AT219868B (fr)
AT216749B (fr)
BE557464A (fr)
BE518340A (fr)
BE562122A (fr)
BE561138A (fr)
BE560415A (fr)
BE558579A (fr)
BE438342A (fr)